Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  HIV Infection

  Free Subscription


Articles published in Lancet

Retrieve available abstracts of 93 articles:
HTML format



Single Articles


    September 2022
  1. LUO R, Fong Y, Boeras D, Jani I, et al
    The clinical effect of point-of-care HIV diagnosis in infants: a systematic review and meta-analysis.
    Lancet. 2022;400:887-895.
    PubMed     Abstract available


  2. TECHNAU KG, Mazanderani AH
    Point-of-care HIV diagnosis for infants: the outcomes we need to achieve.
    Lancet. 2022;400:864-865.
    PubMed    


    August 2022
  3. THORNTON J
    Botswana's HIV/AIDS success.
    Lancet. 2022;400:480-481.
    PubMed    


  4. TARIN-VICENTE EJ, Alemany A, Agud-Dios M, Ubals M, et al
    Clinical presentation and virological assessment of confirmed human monkeypox virus cases in Spain: a prospective observational cohort study.
    Lancet. 2022 Aug 8. pii: S0140-6736(22)01436.
    PubMed     Abstract available


    July 2022
  5. MAYER KH, Phanuphak N, Mgodi N, Grinsztejn B, et al
    New HIV prevention approaches: promise, praxis, and pitfalls.
    Lancet. 2022;400:257-259.
    PubMed    



  6. Population-level risks of alcohol consumption by amount, geography, age, sex, and year: a systematic analysis for the Global Burden of Disease Study 2020.
    Lancet. 2022;400:185-235.
    PubMed     Abstract available


  7. BOOTH A
    New HIV law welcomed in Argentina.
    Lancet. 2022;400:149.
    PubMed    


  8. GOGA A, Bekker LG, Garrett N, Reddy T, et al
    Breakthrough SARS-CoV-2 infections during periods of delta and omicron predominance, South Africa.
    Lancet. 2022 Jul 6. pii: S0140-6736(22)01190.
    PubMed    


    June 2022
  9. CHARANI E, McKee M, Balasegaram M, Mendelson M, et al
    Global burden of antimicrobial resistance: essential pieces of a global puzzle.
    Lancet. 2022;399:2346-2347.
    PubMed    


  10. PAN D, Sze S, Nazareth J, Martin CA, et al
    Monkeypox in the UK: arguments for a broader case definition.
    Lancet. 2022 Jun 15. pii: S0140-6736(22)01101.
    PubMed    


    May 2022
  11. NELLUMS LB, Latif A, Nkhoma K, Timmons S, et al
    COVID-19 boosters and building trust among UK minority ethnic communities.
    Lancet. 2022 May 25. pii: S0140-6736(22)00945.
    PubMed    



  12. Measuring the availability of human resources for health and its relationship to universal health coverage for 204 countries and territories from 1990 to 2019: a systematic analysis for the Global Burden of Disease Study 2019.
    Lancet. 2022 May 23. pii: S0140-6736(22)00532.
    PubMed     Abstract available


  13. WATTS G
    Luc Antoine Montagnier.
    Lancet. 2022;399:1862.
    PubMed    


    April 2022
  14. BUCHBINDER SP, McElrath MJ, Dieffenbach C, Corey L, et al
    COVID-19 vaccination and HIV-1 acquisition - Authors' reply.
    Lancet. 2022;399:e36.
    PubMed    


  15. LOGUNOV DY, Livermore DM, Ornelles DA, Bayer W, et al
    COVID-19 vaccination and HIV-1 acquisition.
    Lancet. 2022;399:e34-e35.
    PubMed    


  16. BLAKNEY AK, Bekker LG
    DNA vaccines join the fight against COVID-19.
    Lancet. 2022;399:1281-1282.
    PubMed    


  17. MUDZINGWA EK, Parker IK
    Long-acting injections for HIV prevention among women in sub-Saharan Africa.
    Lancet. 2022 Apr 1. pii: S0140-6736(22)00613.
    PubMed    


  18. DELANY-MORETLWE S, Hughes JP, Bock P, Ouma SG, et al
    Cabotegravir for the prevention of HIV-1 in women: results from HPTN 084, a phase 3, randomised clinical trial.
    Lancet. 2022 Apr 1. pii: S0140-6736(22)00538.
    PubMed     Abstract available


    March 2022
  19. KRAUSE PR, Rees H, Figueroa JP, Swaminathan S, et al
    Booster vaccines for COVID-19 vaccine breakthrough cases? - Authors' reply.
    Lancet. 2022;399:1225.
    PubMed    


  20. WATERS L, Marra F, Pozniak A, Cockburn J, et al
    Ritonavir and COVID-19: pragmatic guidance is important.
    Lancet. 2022 Mar 22. pii: S0140-6736(22)00280.
    PubMed    


  21. BEKKER LG, Garrett N, Goga A, Fairall L, et al
    Effectiveness of the Ad26.COV2.S vaccine in health-care workers in South Africa (the Sisonke study): results from a single-arm, open-label, phase 3B, implementation study.
    Lancet. 2022;399:1141-1153.
    PubMed     Abstract available



  22. Progress in health among regions of Ethiopia, 1990-2019: a subnational country analysis for the Global Burden of Disease Study 2019.
    Lancet. 2022 Mar 11. pii: S0140-6736(21)02868.
    PubMed     Abstract available


  23. FALLAH MP, Reinhart E
    Apartheid logic in global health.
    Lancet. 2022;399:902-903.
    PubMed    


    February 2022
  24. CHEMAITELLY H, Abu-Raddad LJ
    Waning effectiveness of COVID-19 vaccines.
    Lancet. 2022;399:771-773.
    PubMed    


  25. MADHI SA, Ihekweazu C, Rees H, Pollard AJ, et al
    Decoupling of omicron variant infections and severe COVID-19.
    Lancet. 2022 Feb 18. pii: S0140-6736(22)00109.
    PubMed    


  26. MINALGA B, Chung C, Davids JD, Martin A, et al
    Research on transgender people must benefit transgender people.
    Lancet. 2022;399:628.
    PubMed    


  27. SIVA N
    Gilead and ViiV Healthcare reach settlement over HIV drug.
    Lancet. 2022;399:618.
    PubMed    


  28. HUMPHREYS K, Shover CL, Andrews CM, Bohnert ASB, et al
    Responding to the opioid crisis in North America and beyond: recommendations of the Stanford-Lancet Commission.
    Lancet. 2022;399:555-604.
    PubMed    


  29. BEYRER C
    Archbishop Desmond Tutu and the universality of health and human rights.
    Lancet. 2022;399:503-504.
    PubMed    


  30. VAN DER MERWE LL, Cloete A, Skinner D
    How HIV advocacy can be used to ensure quality transgender health care: lessons from South Africa.
    Lancet. 2022 Feb 4. pii: S0140-6736(22)00177.
    PubMed    


    January 2022
  31. WOLTER N, Jassat W, Walaza S, Welch R, et al
    Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in South Africa: a data linkage study.
    Lancet. 2022 Jan 19. pii: S0140-6736(22)00017.
    PubMed     Abstract available


  32. MCCALL C
    Disrupted care in Papua New Guinea: the harms of COVID-19.
    Lancet. 2022;399:226-227.
    PubMed    


    December 2021
  33. HOY J, McMahon J
    Is it time for injectable antiretroviral therapy for HIV?
    Lancet. 2021;396:1944-1946.
    PubMed    


  34. OVERTON ET, Richmond G, Rizzardini G, Jaeger H, et al
    Long-acting cabotegravir and rilpivirine dosed every 2 months in adults with HIV-1 infection (ATLAS-2M), 48-week results: a randomised, multicentre, open-label, phase 3b, non-inferiority study.
    Lancet. 2021;396:1994-2005.
    PubMed     Abstract available


  35. HOSSEINPOOR AR, Bergen N, Kirkby K, Schlotheuber A, et al
    Monitoring inequalities is a key part of the efforts to end AIDS, tuberculosis, and malaria.
    Lancet. 2021 Dec 8. pii: S0140-6736(21)02756.
    PubMed    


  36. MENDELSON M, Venter F, Moshabela M, Gray G, et al
    The political theatre of the UK's travel ban on South Africa.
    Lancet. 2021 Dec 3. pii: S0140-6736(21)02752.
    PubMed    


    November 2021
  37. SIMBAYI LC, Moyo S, van Heerden A, Zuma K, et al
    Global HIV efforts need to focus on key populations in LMICs.
    Lancet. 2021 Nov 29. pii: S0140-6736(21)02692.
    PubMed    


  38. JOLLY J
    A reproductive justice response to HIV/AIDS and COVID-19.
    Lancet. 2021;398:1958-1959.
    PubMed    


  39. LANE R
    Pascale Ondoa: strengthening laboratory medicine in Africa.
    Lancet. 2021;398:1955.
    PubMed    


  40. FALCARO M, Castanon A, Ndlela B, Checchi M, et al
    The effects of the national HPV vaccination programme in England, UK, on cervical cancer and grade 3 cervical intraepithelial neoplasia incidence: a register-based observational study.
    Lancet. 2021 Nov 3. pii: S0140-6736(21)02178.
    PubMed     Abstract available


    October 2021

  41. Global, regional, and national mortality among young people aged 10-24 years, 1950-2019: a systematic analysis for the Global Burden of Disease Study 2019.
    Lancet. 2021;398:1593-1618.
    PubMed     Abstract available


  42. ADEPOJU P
    Nkengasong tipped to lead PEPFAR.
    Lancet. 2021;398:e15.
    PubMed    


    September 2021
  43. KRAUSE PR, Fleming TR, Peto R, Longini IM, et al
    Considerations in boosting COVID-19 vaccine immune responses.
    Lancet. 2021 Sep 14. pii: S0140-6736(21)02046.
    PubMed    


  44. CARLINO MS, Larkin J, Long GV
    Immune checkpoint inhibitors in melanoma.
    Lancet. 2021;398:1002-1014.
    PubMed     Abstract available


  45. JAFFAR S, Ramaiya K, Karekezi C, Sewankambo N, et al
    Controlling diabetes and hypertension in sub-Saharan Africa: lessons from HIV programmes.
    Lancet. 2021 Sep 7. pii: S0140-6736(21)01731.
    PubMed    


    August 2021
  46. BEYRER C, Adimora AA, Sullivan PS, Fields E, et al
    Ending HIV in the USA: integrating social determinants of health - Authors' reply.
    Lancet. 2021;398:743.
    PubMed    


  47. HODDER SL, Feinberg J, Strathdee SA, Shoptaw S, et al
    HIV and overdoses: diversifying therapies for opioid use disorder - Authors' reply.
    Lancet. 2021;398:742.
    PubMed    


  48. SPRAGUE C, Simon SE
    Ending HIV in the USA: integrating social determinants of health.
    Lancet. 2021;398:742-743.
    PubMed    


  49. WATERS RC, Oviedo-Joekes E, Rawlins J
    HIV and overdoses: diversifying therapies for opioid use disorder.
    Lancet. 2021;398:741-742.
    PubMed    


  50. ZUNIGA JM, Russell A, Lusimbo R, Tshabalala S, et al
    The costs of PEPFAR's leadership vacuum.
    Lancet. 2021;398:741.
    PubMed    


    July 2021
  51. PAN D, Martin CA, Nazareth J, Nevill CR, et al
    Ethnic disparities in COVID-19: increased risk of infection or severe disease?
    Lancet. 2021;398:389-390.
    PubMed    


  52. HILLIS SD, Unwin HJT, Chen Y, Cluver L, et al
    Global minimum estimates of children affected by COVID-19-associated orphanhood and deaths of caregivers: a modelling study.
    Lancet. 2021 Jul 20. pii: S0140-6736(21)01253.
    PubMed     Abstract available


  53. FISSEHA S, Sen G, Ghebreyesus TA, Byanyima W, et al
    COVID-19: the turning point for gender equality.
    Lancet. 2021 Jul 16. pii: S0140-6736(21)01651.
    PubMed    


  54. FIELDS EL, Copeland R, Hopkins E, Sanders RA, et al
    Surviving syndemics - Authors' reply.
    Lancet. 2021;398:119.
    PubMed    


  55. SAMARASEKERA U
    Etheldreda Nakimuli-Mpungu: innovator in mental health.
    Lancet. 2021;398:109.
    PubMed    


    June 2021
  56. BEYRER C
    A pandemic anniversary: 40 years of HIV/AIDS.
    Lancet. 2021;397:2142-2143.
    PubMed    


  57. SAMARASEKERA U
    40 years of HIV/AIDS: an interview with Peter Piot.
    Lancet. 2021;397:2138-2139.
    PubMed    


  58. CORNELL M, Majola M, Johnson LF, Dubula-Majola V, et al
    HIV services in sub-Saharan Africa: the greatest gap is men.
    Lancet. 2021;397:2130-2132.
    PubMed    


  59. THE LANCET
    40 years of HIV/AIDS: a painful anniversary.
    Lancet. 2021;397:2125.
    PubMed    


    May 2021
  60. MAKONI M
    Africa's need for more COVID-19 clinical trials.
    Lancet. 2021;397:2037.
    PubMed    



  61. Patient care and clinical outcomes for patients with COVID-19 infection admitted to African high-care or intensive care units (ACCCOS): a multicentre, prospective, observational cohort study.
    Lancet. 2021;397:1885-1894.
    PubMed     Abstract available


  62. SAMARASEKERA U
    Yee-Sin Leo: a leader in Singapore's fight against infectious diseases.
    Lancet. 2021;397:1873.
    PubMed    


    April 2021
  63. WALTER KS, Martinez L, Arakaki-Sanchez D, Sequera VG, et al
    The escalating tuberculosis crisis in central and South American prisons.
    Lancet. 2021 Apr 8. pii: S0140-6736(20)32578.
    PubMed     Abstract available


  64. VAN DE PERRE P, Goga A, Ngandu N, Nagot N, et al
    Eliminating postnatal HIV transmission in high incidence areas: need for complementary biomedical interventions.
    Lancet. 2021;397:1316-1324.
    PubMed     Abstract available


  65. LOCKMAN S, Brummel SS, Ziemba L, Stranix-Chibanda L, et al
    Efficacy and safety of dolutegravir with emtricitabine and tenofovir alafenamide fumarate or tenofovir disoproxil fumarate, and efavirenz, emtricitabine, and tenofovir disoproxil fumarate HIV antiretroviral therapy regimens started in pregnancy (IMPAA
    Lancet. 2021;397:1276-1292.
    PubMed     Abstract available


  66. GILLEECE Y, Krankowska D
    ART in pregnant women living with HIV.
    Lancet. 2021;397:1240-1241.
    PubMed    


    March 2021

  67. Human rights and fair access to COVID-19 vaccines: the International AIDS Society-Lancet Commission on Health and Human Rights.
    Lancet. 2021 Mar 24. pii: S0140-6736(21)00708.
    PubMed    


  68. LANE R
    Nicole Salazar-Austin: emerging tuberculosis-HIV research leader.
    Lancet. 2021 Mar 18. pii: S0140-6736(21)00587.
    PubMed    


    February 2021
  69. BENJAMIN LA, Phiri T, Simister R, Solomon T, et al
    Recognising HIV infection in systems of care for stroke.
    Lancet. 2021;397:794.
    PubMed    


  70. PANDIAN JD, Kalkonde Y, Sebastian IA, Bosch J, et al
    Recognising HIV infection in systems of care for stroke - Authors' reply.
    Lancet. 2021;397:794-795.
    PubMed    


  71. PRENDECKI M, Clarke C, Brown J, Cox A, et al
    Effect of previous SARS-CoV-2 infection on humoral and T-cell responses to single-dose BNT162b2 vaccine.
    Lancet. 2021 Feb 25. pii: S0140-6736(21)00502.
    PubMed    


  72. VOYSEY M, Costa Clemens SA, Madhi SA, Weckx LY, et al
    Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials.
    Lancet. 2021 Feb 19. pii: S0140-6736(21)00432.
    PubMed     Abstract available


  73. KATES J, Dawson L, Horn TH, Killelea A, et al
    Insurance coverage and financing landscape for HIV treatment and prevention in the USA.
    Lancet. 2021 Feb 18. pii: S0140-6736(21)00397.
    PubMed     Abstract available


  74. SULLIVAN PS, Satcher Johnson A, Pembleton ES, Stephenson R, et al
    Epidemiology of HIV in the USA: epidemic burden, inequities, contexts, and responses.
    Lancet. 2021 Feb 18. pii: S0140-6736(21)00395.
    PubMed     Abstract available


  75. FIELDS EL, Copeland R, Hopkins E
    Same script, different viruses: HIV and COVID-19 in US Black communities.
    Lancet. 2021 Feb 18. pii: S0140-6736(20)32522.
    PubMed    


  76. MAYER KH, Nelson L, Hightow-Weidman L, Mimiaga MJ, et al
    The persistent and evolving HIV epidemic in American men who have sex with men.
    Lancet. 2021 Feb 18. pii: S0140-6736(21)00321.
    PubMed     Abstract available


  77. BEYRER C, Adimora AA, Hodder SL, Hopkins E, et al
    Call to action: how can the US Ending the HIV Epidemic initiative succeed?
    Lancet. 2021 Feb 18. pii: S0140-6736(21)00390.
    PubMed     Abstract available


  78. HODDER SL, Feinberg J, Strathdee SA, Shoptaw S, et al
    The opioid crisis and HIV in the USA: deadly synergies.
    Lancet. 2021 Feb 18. pii: S0140-6736(21)00391.
    PubMed     Abstract available


  79. ADIMORA AA, Ramirez C, Poteat T, Archin NM, et al
    HIV and women in the USA: what we know and where to go from here.
    Lancet. 2021 Feb 18. pii: S0140-6736(21)00396.
    PubMed     Abstract available


  80. RODRIGUEZ-DIAZ CE, Martinez O, Bland S, Crowley JS, et al
    Ending the HIV epidemic in US Latinx sexual and gender minorities.
    Lancet. 2021 Feb 18. pii: S0140-6736(20)32521.
    PubMed    


    January 2021
  81. SINGH NS, Ataullahjan A, Ndiaye K, Das JK, et al
    Delivering health interventions to women, children, and adolescents in conflict settings: what have we learned from ten country case studies?
    Lancet. 2021 Jan 22. pii: S0140-6736(21)00132.
    PubMed     Abstract available


  82. THORNTON J
    Expanding HIV-positive organ donation.
    Lancet. 2021;397:184-185.
    PubMed    


  83. LANE R
    Anne Johnson: Dame of public health epidemiology.
    Lancet. 2021;397:186.
    PubMed    


    December 2020
  84. BURKI T
    Cheaper HIV treatment for children.
    Lancet. 2020;396:1873.
    PubMed    


  85. VOYSEY M, Clemens SAC, Madhi SA, Weckx LY, et al
    Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK.
    Lancet. 2020 Dec 8. pii: S0140-6736(20)32661.
    PubMed     Abstract available


    November 2020
  86. THE LANCET
    Maintaining the HIV response in a world shaped by COVID-19.
    Lancet. 2020;396:1703.
    PubMed    


  87. BEYRER C, Sullivan P, Adimora AA, Mayer K, et al
    HIV in the USA: priorities for the new administration.
    Lancet. 2020 Nov 27. pii: S0140-6736(20)32524.
    PubMed    


  88. GOGA A, Bekker LG, Van de Perre P, El-Sadr W, et al
    Centring adolescent girls and young women in the HIV and COVID-19 responses.
    Lancet. 2020 Nov 27. pii: S0140-6736(20)32552.
    PubMed    


    October 2020
  89. KENYON C
    Syndemic responses to COVID-19 should include an ecological dimension.
    Lancet. 2020 Oct 27. pii: S0140-6736(20)32219.
    PubMed    


  90. BUCHBINDER SP, McElrath MJ, Dieffenbach C, Corey L, et al
    Use of adenovirus type-5 vectored vaccines: a cautionary tale.
    Lancet. 2020 Oct 19. pii: S0140-6736(20)32156.
    PubMed    



  91. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.
    Lancet. 2020;396:1204-1222.
    PubMed     Abstract available



  92. Global age-sex-specific fertility, mortality, healthy life expectancy (HALE), and population estimates in 204 countries and territories, 1950-2019: a comprehensive demographic analysis for the Global Burden of Disease Study 2019.
    Lancet. 2020;396:1160-1203.
    PubMed     Abstract available


  93. MCMAHON JH, Hoy JF, Kamarulzaman A, Bekker LG, et al
    Leveraging the advances in HIV for COVID-19.
    Lancet. 2020;396:943-944.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO HIV Infection is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: